360 High-Risk Vulnerability Immunization Tool V2.0 vs Avira Antivirus Pro: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Avira Antivirus Pro: Antivirus software for Windows and Mac with malware and ransomware protection. built by Avira. Core capabilities include Real-time malware protection, Ransomware detection and blocking, Web protection against infected sites..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Avira Antivirus Pro differentiates with Real-time malware protection, Ransomware detection and blocking, Web protection against infected sites.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Avira Antivirus Pro is developed by Avira. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Avira Antivirus Pro serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Windows Security. Review the feature comparison above to determine which fits your requirements.